Ocop, Baby Girl .

HRN: 29-04-65  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/30/2026
06/06/2026
IV
60mg
Q 24
PSNB
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines